Storia in 3 fonti

The smart way to regulate the peptide boom

“The FDA should pursue a structured, clinician-guided framework” on popular peptides, writes former surgeon general Jerome Adams.

Raccontata da

statnews.com

washingtonexaminer.com

npr.org

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

statnews.comStai leggendo5 g fa

The smart way to regulate the peptide boom

“The FDA should pursue a structured, clinician-guided framework” on popular peptides, writes former surgeon general Jerome Adams.

originale

washingtonexaminer.com4 g fa

Peptide exceptionalism is a dangerous FDA loophole

If a compound is powerful enough to treat disease, alter metabolism, or change human physiology, it is powerful enough to harm.

Leggi questa versione → originale

npr.org4 g fa

What's behind the push to make peptide therapies more readily available

Marketed for longevity and wellness benefits, the unproven therapies are sold through a grey market online. Compounding pharmacies say they should be able to make them legally to meet demand.

Leggi questa versione → originale

Timeline cronologica

lunedì 6 luglio 2026·statnews.com
The smart way to regulate the peptide boom
“The FDA should pursue a structured, clinician-guided framework” on popular peptides, writes former surgeon general Jerome Adams.
martedì 7 luglio 2026·washingtonexaminer.com
Peptide exceptionalism is a dangerous FDA loophole
If a compound is powerful enough to treat disease, alter metabolism, or change human physiology, it is powerful enough to harm.
mercoledì 8 luglio 2026·npr.org
What's behind the push to make peptide therapies more readily available
Marketed for longevity and wellness benefits, the unproven therapies are sold through a grey market online. Compounding pharmacies say they should be able to make them legally to…